Combining angiotensin II receptor 1 antagonism and neprilysin inhibition for the treatment of heart failure.

Katsanos S, Bistola V, Parissis JT

Open source

DOI
10.1586/17512433.2016.1153423
Published
2016 Apr
Container
Expert review of clinical pharmacology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1586/17512433.2016.1153423,
  title = {Combining angiotensin II receptor 1 antagonism and neprilysin inhibition for the treatment of heart failure.},
  author = {Katsanos S and Bistola V and Parissis JT},
  year = {2016},
  journal = {Expert review of clinical pharmacology},
  doi = {10.1586/17512433.2016.1153423},
  url = {https://doi.org/10.1586/17512433.2016.1153423}
}

RIS

TY  - JOUR
TI  - Combining angiotensin II receptor 1 antagonism and neprilysin inhibition for the treatment of heart failure.
AU  - Katsanos S
AU  - Bistola V
AU  - Parissis JT
PY  - 2016
JO  - Expert review of clinical pharmacology
DO  - 10.1586/17512433.2016.1153423
UR  - https://doi.org/10.1586/17512433.2016.1153423
ER  - 

APA

S, K., V, B., & JT, P. (2016). Combining angiotensin II receptor 1 antagonism and neprilysin inhibition for the treatment of heart failure.. Expert review of clinical pharmacology. https://doi.org/10.1586/17512433.2016.1153423

Source records